In this supplement to EMJ Hematology, two leading haematologists, Prof Adriano Venditti and Prof Lars Bullinger, discussed the management of patients with acute myeloid leukaemia (AML) and fms-related tyrosine kinase 3 (FLT3) gene mutations. Specifically, the roles for emerging treatment options and maintenance strategies in improving outcomes for patients with a FLT3 internal tandem duplication (ITD) mutation were explored.
Latest articles
All articles![](https://www.emjreviews.com/wp-content/uploads/2024/08/Current-Management-of-Warm-Autoimmune-Haemolytic-Anaemia-and-Recent-Advancements-in-Research-Interview-with-a-Key-Opinion-Leader-Web-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/07/Filgrastim-Prophylaxis-for-Neutropenia-in-Myelodysplasia-Pre-Surgery-Case-Report-Web-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/07/Diffuse-Large-B-Cell-Lymphoma-of-Spleen-A-Key-Differential-of-Nodular-Splenomegaly-940x564.jpg)
![](https://www.emjreviews.com/wp-content/uploads/2024/07/The-Impact-of-‘Pre-conception-on-Conception-An-Inadvertent-Form-of-Infertility-Web-940x564.jpg)